Skip to Navigation Skip to Search Skip to Content
Search All Centers

STOMP Clinical Trial Tests Selinexor Combination Therapies

Published on May 11, 2021

What Is the STOMP Clinical Trial?

In this Multiple Myeloma Ask the Expert segment, Patient Power co-founder and patient advocate Andrew Schorr talks to Dr. Clifton Mo, MD, Medical Oncologist and Director of Autologous Stem Cell Transplantation for Multiple Myeloma at the Dana-Farber Cancer Institute, about the Selinexor and Backbone Treatments of Multiple Myeloma Patients (STOMP) clinical trial. It is a Phase I/Phase II trial utilizing selinexor (Xpovio) in multiple triplet combination therapies.

Recommended Programs: